LTGO - Latigo Biotherapeutics, Inc. Common Stock

Latigo Biotherapeutics, Inc. (LTGO)

NGS · Common · CUSIP 517954103

Last Price•••.••

Current Yield•.••%

Yield to Call•.••%

Yield to Worst•.••%

Free registration unlocks the quote, yield calculations, price chart and full fundamentals for LTGO and every other security on QuantumOnline.

Overview Financials 🔒 Earnings 🔒 Dividends 🔒 Analysts 🔒 Ownership 🔒 ESG 🔒 Technicals 🔒

🔒

Price chart and 15 days of daily prices

Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type: Common Stock
CUSIP: 517954103
IPO: 8/7/2026 · $18.00/share

Links: Home Page Investor Relations News

Business: Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction

Company Contact

CEO: Nima Farzan
CFO: Neha Krishnamohan
Headquarters: 1300 Rancho Conejo Boulevard, Suite 305, Thousand Oaks, CA 91320
Phone: 805-716-2927
Investor Relations: Neha Krishnamohan, · ir@latigobio.com
Email Form: Contact Form »
SEC EDGAR Filings: View filings »